Ebo Bos
Impact in
- Immunology top 10%
- T-cell and B-cell Immunology
- Invertebrate Immune Response Mechanisms
- Galectins and Cancer Biology
- Physiology top 5%
Papers in
-
- Glycosylation and Glycoproteins Research 5
- vaccines and immunoinformatics approaches 4
-
- Monoclonal and Polyclonal Antibodies Research 16
- Co-authors
- Geert AB (2 shared papers)Max Gruber (2 shared papers)Annemieke M. H. Boots (6 shared papers)Bauke W. Dijkstra (1 shared paper)Kor H. Kalk (1 shared paper)Fabrizia Fusetti (1 shared paper)Tjaard Pijning (1 shared paper)Filip De Keyser (5 shared papers)
- Journals
- Bioconjugate Chemistry (3 papers)Journal of Controlled Release (3 papers)ChemMedChem (2 papers)The Journal of Immunology (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Ebo Bos
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Immunology 367
- Physiology 73
- Reproductive Medicine 102
- Radiology, Nuclear Medicine and Imaging 256
- Molecular Biology 677
Countries citing papers authored by Ebo Bos
This map shows the geographic impact of Ebo Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebo Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebo Bos more than expected).
Fields of papers citing papers by Ebo Bos
This network shows the impact of papers produced by Ebo Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebo Bos. The network helps show where Ebo Bos may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebo Bos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 191 | |
| 2 | 1997 | 166 | |
| 3 | 1974 | 159 | |
| 4 | 2000 | 143 | |
| 5 | 2000 | 97 | |
| 6 | 1993 | 74 | |
| 7 | 1976 | 61 | |
| 8 | 2003 | 51 | |
| 9 | 1999 | 35 | |
| 10 | 1999 | 31 | |
| 11 | 2009 | 30 | |
| 12 | 1972 | 29 | |
| 13 | 2018 | 28 | |
| 14 | 1970 | 28 | |
| 15 | 1995 | 27 | |
| 16 | 2001 | 19 | |
| 17 | 2008 | 18 | |
| 18 | 2007 | 18 | |
| 19 | 2011 | 15 | |
| 20 | Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine. | 1993 | 15 |
About Ebo Bos
Ebo Bos is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Pharmacology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), Immunotherapy and Immune Responses (6 papers), Glycosylation and Glycoproteins Research (5 papers), Peptidase Inhibition and Analysis (4 papers), vaccines and immunoinformatics approaches (4 papers), Galectins and Cancer Biology (3 papers), Hypothalamic control of reproductive hormones (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (367 citations), Physiology (73 citations), Reproductive Medicine (102 citations), Radiology, Nuclear Medicine and Imaging (256 citations) and Molecular Biology (677 citations). Ebo Bos has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Geert AB, Max Gruber, Annemieke M. H. Boots, Bauke W. Dijkstra, Kor H. Kalk, Fabrizia Fusetti, Tjaard Pijning, Filip De Keyser, Gijs Verheijden and André M. M. Miltenburg. Their work appears in journals such as Bioconjugate Chemistry, Journal of Controlled Release, ChemMedChem, The Journal of Immunology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.